Ubs Oconnor LLC Praxis Precision Medicines, Inc. Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $484,341 - $688,581	583,544 New	583,544 $671 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $295,819 - $1.84 Million	369,774 Added 268.96%	507,258 $410,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $40,811 - $791,256	21,708 Added 18.75%	137,484 $0
Q3 2022 Nov 14, 2022	SELL	$2.5 - $37.95 $250,000 - $3.8 Million	-100,000 Reduced 46.34%	115,776 $263 Million
Q2 2022 Aug 12, 2022	BUY	$1.75 - $11.34 $281,358 - $1.82 Million	160,776 Added 292.32%	215,776 $528,000
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $561,550 - $1.12 Million	55,000 New	55,000 $561,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.